Mercure Pharmaceuticals (Opc) Private Limited - Company Profile

It is a pharma enterprise based in Indore, Madhya Pradesh, India, established in 2016.
2016 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Mercure Pharmaceuticals (Opc) Private Limited

Mercure Pharmaceuticals (Opc) Private Limited, Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24290MP2016OPC041240. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Siddhant Jain (Director). It holds ₹2.94 Cr open charges and ₹6.41 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 46, 2Nd Floor Dawa Bazar, Indore, Madhya Pradesh, 452001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290MP2016OPC041240

  • Registration Number

    041240

  • Incorporation Date

    01 August 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.94 Cr
  • Satisfied Charges ₹ 6.41 Cr
  • Revenue Growth **** -6.42%
  • Profit Growth **** 15.22%
  • Ebitda **** 35.38%
  • Net Worth 19.42%
  • Total Assets -17.47%
Company report

Mercure Pharmaceuticals (Opc) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mercure Pharmaceuticals (Opc) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Mercure Pharmaceuticals (Opc) Private Limited?
Current Directors
Name Designation Appointment Date Status
Siddhant Jain Director 01 Aug 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mercure Pharmaceuticals (Opc).

Mercure Pharmaceuticals (Opc) Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.42% decrease. The company also saw a substantial improvement in profitability, with a 15.22% increase in profit. The company's net worth Soared by an impressive increase of 19.42%.

Mercure Pharmaceuticals (Opc) revenue growth over time
Mercure Pharmaceuticals (Opc) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -6.42%
*******
*******
*******
*******
Revenue from Operations
*******
 -5.96%
*******
*******
*******
*******
Total Assets
*******
 -17.47%
*******
*******
*******
*******
Profit or Loss
*******
 15.22%
*******
*******
*******
*******
Net Worth
*******
 19.42%
*******
*******
*******
*******
EBITDA
*******
 35.38%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mercure Pharmaceuticals (Opc)?

In 2023, Mercure Pharmaceuticals (Opc) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹29,400,000.00

Satisfied Charges

₹64,100,000.00

Charges Breakdown by Lending Institutions
  • Others : 2.94 Cr
Latest Charge Details
Date Lender Amount Status
20 Feb 2025 Others ₹2.76 Cr Open
30 Dec 2023 Others ₹1.80 M Open
25 Feb 2021 Hdfc Bank Limited ₹3.20 Cr Satisfied
25 Jun 2020 Others ₹3.10 M Satisfied
13 Jun 2019 Others ₹2.90 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Mercure Pharmaceuticals (Opc)?

Unlock and access historical data on people associated with Mercure Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mercure Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mercure Pharmaceuticals (Opc)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mercure Pharmaceuticals (Opc)
Recent Activity within the Organization
  • Annual General Meeting

    Mercure Pharmaceuticals (Opc) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Mercure Pharmaceuticals (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was documented.

  • Charges

    A charge with Others amounted to Rs. 27.60 M with Charge ID 101053077 was registered on 20 Feb 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 1.80 M with Charge ID 100899725 was registered on 30 Dec 2023. was documented.

  • Charges

    A charge registered on 25 Jun 2020 via Charge ID 100354278 with Others was fully satisfied on 22 Jul 2022. was recorded as a recent event.

  • Charges

    A charge registered on 13 Jun 2019 via Charge ID 100272600 with Others was fully satisfied on 22 Jul 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mercure Pharmaceuticals (Opc) Private Limited?

The CIN of Mercure Pharmaceuticals (Opc) Private Limited is U24290MP2016OPC041240.

Where is Mercure Pharmaceuticals (Opc) Private Limited headquartered?

Mercure Pharmaceuticals (Opc) Private Limited is headquartered at 46, 2Nd Floor Dawa Bazar, Indore, Madhya Pradesh, 452001.

When was Mercure Pharmaceuticals (Opc) Private Limited incorporated?

Mercure Pharmaceuticals (Opc) Private Limited was incorporated on 01 August 2016.

Who are the current directors of Mercure Pharmaceuticals (Opc) Private Limited?

The current directors of Mercure Pharmaceuticals (Opc) Private Limited are

What is the primary industry of Mercure Pharmaceuticals (Opc) Private Limited?

The primary industry of Mercure Pharmaceuticals (Opc) Private Limited is Trade.

Is Mercure Pharmaceuticals (Opc) Private Limited a listed company?

Mercure Pharmaceuticals (Opc) Private Limited is unlisted.

What is the capital structure of Mercure Pharmaceuticals (Opc) Private Limited?

The authorized capital of Mercure Pharmaceuticals (Opc) Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Mercure Pharmaceuticals (Opc) Private Limited?

The compliance status of Mercure Pharmaceuticals (Opc) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available